Submitted by Anonymous (not verified) on 20 October 2025 - 10:30
Opinion/decision on a Paediatric investigation plan (PIP): Xevudy, sotrovimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0334/2024
Source: